These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 19472311)
1. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Zhang X; Liu S; Hu T; Liu S; He Y; Sun S Hepatology; 2009 Aug; 50(2):490-9. PubMed ID: 19472311 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling. Zhang Y; Wei W; Cheng N; Wang K; Li B; Jiang X; Sun S Hepatology; 2012 Nov; 56(5):1631-40. PubMed ID: 22610915 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin. Huang JF; Guo YJ; Zhao CX; Yuan SX; Wang Y; Tang GN; Zhou WP; Sun SH Hepatology; 2013 May; 57(5):1882-92. PubMed ID: 23239537 [TBL] [Abstract][Full Text] [Related]
4. miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A. Wei X; Xiang T; Ren G; Tan C; Liu R; Xu X; Wu Z Cell Signal; 2013 Feb; 25(2):439-46. PubMed ID: 23124077 [TBL] [Abstract][Full Text] [Related]
5. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma. Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561 [TBL] [Abstract][Full Text] [Related]
6. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma. Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma. Chan CF; Yau TO; Jin DY; Wong CM; Fan ST; Ng IO Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4140-9. PubMed ID: 15217951 [TBL] [Abstract][Full Text] [Related]
8. miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3. Fan CG; Wang CM; Tian C; Wang Y; Li L; Sun WS; Li RF; Liu YG Oncol Rep; 2011 Nov; 26(5):1281-6. PubMed ID: 21725618 [TBL] [Abstract][Full Text] [Related]
9. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5. Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554 [TBL] [Abstract][Full Text] [Related]
10. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma. Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240 [TBL] [Abstract][Full Text] [Related]
11. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis. Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132 [TBL] [Abstract][Full Text] [Related]
12. HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma. Qiu X; Dong S; Qiao F; Lu S; Song Y; Lao Y; Li Y; Zeng T; Hu J; Zhang L; Zhang L; Fan H Oncogene; 2013 Jul; 32(27):3296-305. PubMed ID: 23604124 [TBL] [Abstract][Full Text] [Related]
13. HBV suppresses ZHX2 expression to promote proliferation of HCC through miR-155 activation. Song X; Tan S; Wu Z; Xu L; Wang Z; Xu Y; Wang T; Gao C; Gong Y; Liang X; Gao L; Spear BT; Ma C Int J Cancer; 2018 Dec; 143(12):3120-3130. PubMed ID: 29752719 [TBL] [Abstract][Full Text] [Related]
14. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Huang J; Wang Y; Guo Y; Sun S Hepatology; 2010 Jul; 52(1):60-70. PubMed ID: 20578129 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Wong QW; Lung RW; Law PT; Lai PB; Chan KY; To KF; Wong N Gastroenterology; 2008 Jul; 135(1):257-69. PubMed ID: 18555017 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma. Wei X; Tan C; Tang C; Ren G; Xiang T; Qiu Z; Liu R; Wu Z Cell Signal; 2013 May; 25(5):1037-43. PubMed ID: 23376496 [TBL] [Abstract][Full Text] [Related]
17. Sulfatide epigenetically regulates miR-223 and promotes the migration of human hepatocellular carcinoma cells. Dong YW; Wang R; Cai QQ; Qi B; Wu W; Zhang YH; Wu XZ J Hepatol; 2014 Apr; 60(4):792-801. PubMed ID: 24333181 [TBL] [Abstract][Full Text] [Related]
18. The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2. Wong CC; Wong CM; Tung EK; Au SL; Lee JM; Poon RT; Man K; Ng IO Gastroenterology; 2011 Jan; 140(1):322-31. PubMed ID: 20951699 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus X protein promotes CREB-mediated activation of miR-3188 and Notch signaling in hepatocellular carcinoma. Zhou SJ; Deng YL; Liang HF; Jaoude JC; Liu FY Cell Death Differ; 2017 Sep; 24(9):1577-1587. PubMed ID: 28574502 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression. Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]